Literature DB >> 9552854

Management of aseptic meningitis secondary to intravenous immunoglobulin.

S Jolles, H Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9552854      PMCID： PMC1112825     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Aseptic meningitis associated with high dose immunoglobulin: case report.

Authors:  P Picton; M Chisholm
Journal:  BMJ       Date:  1997-11-08

Review 2.  Adverse effects of intravenous immunoglobulin.

Authors:  S A Misbah; H M Chapel
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606
  2 in total
  5 in total

Review 1.  Adverse effects of intravenous immunoglobulin therapy.

Authors:  U E Nydegger; M Sturzenegger
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

Review 2.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

3.  In vivo modulation of cytokine synthesis by intravenous immunoglobulin.

Authors:  W A Sewell; M E North; R Cambronero; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency.

Authors:  K Kaarthigeyan; Vasu V Burli
Journal:  J Pediatr Neurosci       Date:  2011-07

Review 5.  Aseptic Meningitis in Oral Medicine: Exploring the Key Elements for a Challenging Diagnosis: A Review of the Literature and Two Case Reports.

Authors:  Stefania Leuci; Noemi Coppola; Tiziana Cantile; Elena Calabria; Laurenta Lelia Mihai; Michele Davide Mignogna
Journal:  Int J Environ Res Public Health       Date:  2022-03-25       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.